No human protein is exempt from bacterial motifs, not even one

Self/Nonself - Immune Recognition and Signaling

Volumn 1, Issue 4, 2010, Pages 328-334

  Trost, Brett ^a   Lucchese, Guglielmo ^b   Stufano, Angela ^b   Bickis, Mik ^a   Kusalik, Anthony ^a   Kanduc, Darja ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmunity; Bacterial versus human peptide overlap; Microbial immune escape; Molecular mimicry; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; HEPTAPEPTIDE; HEXAPEPTIDE; OCTAPEPTIDE; PENTAPEPTIDE;

ALCANIVORAX; ALCANIVORAX BORKUMENSIS; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; BORDETELLA PERTUSSIS; BORRELIA BURGDORFERI; BRUCELLA ABORTUS; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; DESULFITOBACTERIUM HAFNIENSE; ENTEROCOCCUS FAECALIS; FRANCISELLA TULARENSIS; GLOEOBACTER VIOLACEUS; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOCOCCUS LACTIS; LEGIONELLA PNEUMOPHILA; LEUCONOSTOC MESENTEROIDES; METHYLIBIUM PETROLEIPHILUM; MOLECULAR MIMICRY; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PARACOCCUS DENITRIFICANS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN MOTIF; PSEUDOMONAS PUTIDA; RICKETTSIA RICKETTSII; SALINISOPORA TROPICA; SALMONELLA TYPHIMURIUM; SINORHIZOBIUM MEDICAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS THERMOPHILUS; TREPONEMA PALLIDUM; VIBRIO CHOLERAE; XANTHOBACTER AUTOTROPHICAS; YERSINIA PESTIS;

EID: 79851499443     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.1.4.13315     Document Type: Article

References (56)

1. Redelings MD, McCoy L, Sorvillo F. Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology 2006; 26:102-7.
2. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373:2027-33.
3. Stark W, Huppke P, Gärtner J. Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in childhood and adolescence. J Neurol 2008; 255:119-22.
4. Ramírez-Zamora M, Burgos-Ganuza CR, Alas-Valle DA, Vergara-Galán PE, Ortez-González CI. Guillain-Barre syndrome in the paediatric age: epidemiological, clinical and therapeutic profile in a hospital in El Salvador. Rev Neurol 2009; 48:292-6.
5. Lernmark Å. Autoimmune diseases: are markers ready for prediction? J Clin Invest 2001; 108:1091-6.
6. Oldstone MBA. Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol 1989; 145:127-35.
7. Li de la Sierra I, Pernot L, Prangé T, Saludjian P, Schiltz M, Fourme R, et al. Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J Mol Biol 1997; 269:129-41.
8. Karges WJ, Ilonen J, Robinson BH, Dosch HM. Self and nonself antigen in diabetic autoimmunity: Molecules and mechanisms. Mol Aspects Med 1995; 16:179-213.
9. Karopoulos C, Rowley MJ, Handley CJ, Strugnell RA. Antibody reactivity to mycobacterial 65 kDa heat shock protein: relevance to autoimmunity. J Autoimmun 1995; 8:235-48.
10. Steinman L, Oldstone MB. More mayhem from molecular mimics. Nat Med 1997; 3:1321-2.
11. O'Donohue J, McFarlane B, Bomford A, Yates M, Williams R. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol 1994; 21:887-9.
12. Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre' syndrome: evidence of molecular mimicry. Ann Neurol 1995; 38:170-5.
13. Maclaren NK, Alkinson MA. Insulin-dependent diabetes mellitus: The hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol Med Today 1997; 3:76-83.
14. Markesich DC, Sawai ET, Butel JS, Graham DY. Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins. Dig Dis Sci 1991; 36:454-60.
15. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 2003; 8:533-43.
16. Lamb DJ, El-Sankary W, Ferns GA. Molecular mimicry in atherosclerosis: a role for heat shock proteins inimmunisation. Atherosclerosis 2003; 167:177-85.
17. Waisbren BA Sr. Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic ajuvant and specific HLA patterns. Med Hypotheses 2008; 70:346-8.
18. Swanborg RH, Boros DL, Whittum-Hudson JA, Hudson AP. Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med 2006; 8:1-23.
19. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006; 39:41-54.
20. Kusalik A, Bickis M, Lewis C, Li Y, Lucchese G, Marincola FM, et al. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007; 28:1260-7.
21. Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides 2008; 29:1755-66.
22. Trost B, Kusalik A, Lucchese G, Kanduc D. Bacterial peptides are intensively present throughout the human proteome. Self/Nonself 2010; 1:1-4.
23. Kersey P, Bower L, Morris L, Horne A, Petryszak R, Kanz C, et al. Integr8 and Genome Reviews: integrated views of complete genomes and proteomes. Nucleic Acids Res 2005; 33:297-302.
24. Gusfield D. Algorithms on Strings, Trees and Sequences: Computer Science and Computational Biology. Cambridge University Press 1997.
25. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8.
26. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-20.
27. Ewing C, Ebringer R, Tribbick G, Geysen HM. Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85) and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). J Exp Med 1990; 171:1635-47.
28. Schwimmbeck PL, Wu DTY, Oldstone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166:173.
29. Ebringer A, Cowling P, Ngwa-Suh N, James DCO, Ebringer R. Crossreactivity between Klebsiella aerogenes species and B27 lymphocyte antigens as an aetiological factor in ankylosing spondylitis. In: HLA and Disease J. Dausset and A. Svejgaard, editors. INSERM, Paris 1976; 58:27.
30. Schwimmbeck PL, Oldstone MBA. Autoimmune pathogenesis for ankylosing spondylitis (AS) and Reiter's syndrome (RS): autoantibodies against an epitope shared by HLA B27 and Klebsiella pneumoniae nitrogenase in sera of patients with AS and RS. Trans Assoc Am Phys 1987; 100:28-39.
31. Schwimmbeck PL, Oldstone MBA. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies. Am J Med 1988; 85:51-3.
32. Husby G, Tsuchiya N, Schwimmbeck PL, Keat A, Pahle JA, Oldstone MBA. Williams RC Jr. Crossreactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27 positive patients with ankylosing spondylitis. Arthr Rheum 1989; 32:437-45.
33. Ogawasara M, Kono DH, Yu DTY. Mimicry of human histocompatibility HLA B27 antigens by Klebsiella pneumoniae. Infect Immun 1986; 51:901-8.
34. Wilson C, Tiwana H, Ebringer A. Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the aetiological basis for autoimmunity. Microbes Infect 2000; 2:1489-96.
35. Kusalik A, Trost B, Bickis M, Fasano C, Capone G, Kanduc D. Codon number shapes peptide redundancy in the universal proteome composition. Peptides 2009; 30:1940-4.
36. Capone G, Novello G, Fasano C, Trost B, Bickis M, Kusalik A, et al. The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand. BMC Bioinformatics 2010; 11:383.
37. Cavalier-Smith T. Predation and eukaryote cell origins: a coevolutionary perspective. Int J Biochem Cell Biol 2009; 41:307-22.
38. Datta S, Panigrahi R, Biswas A, Chandra PK, Banerjee A, Mahapatra PK, et al. Genetic characterization of Hepatitis B virus in peripheral blood leukocytes: Evidence for selection and compartmentalization of viral variants with immune escape G145R mutation. J Virol 2009; 83:9983-92.
39. Middeldorp JM, Pegtel DM. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 2008; 18:388-96.
40. van Kooyk Y, Appelmelk B, Geijtenbeek TB. A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance. Trends Mol Med 2003; 9:153-9.
41. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195:221-31.
42. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-25.
43. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-7.
44. Kinane DF, Marshall GJ. Periodontal manifestations of systemic disease. Aust Dent J 2001; 46:2-12.
45. Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment and prevention. Med Clin North Am 2005; 89:313-44.
46. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54:1-13.
47. Havarinasab S, Pollard KM, Hultman P. Gold- and silver-induced murine autoimmunity requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol 2009; 155:567-76.
48. Mizrahi M, Lalazar G, Ben Ya'acov A, Livovsky DM, Horowitz Y, Zolotarov L, et al. Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination. Vaccine 2008; 26:2589-95.
49. Fraser CK, Diener KR, Brown MP, Hayball JD. Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 2007; 6:559-78.
50. Schmidt CS, Morrow WJ, Sheikh NA. Smart adjuvants. Expert Rev Vaccines 2007; 6:391-400.
51. Bryan JT. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine 2007; 25:3001-6.
52. Halperin SA, Dobson S, McNeil S, Langley JM, Smith B, McCall-Sani R, et al. Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphoro-thioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults. Vaccine 2006; 24:20-6.
53. Mandavilli A. When the vaccine causes disease Nat Med 2007; 13:274.
54. Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 2008; 8:970-6.
55. Kanduc D. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol 2009; 8:65-76.
56. Ricco R, Kanduc D. Hepatitis B virus and Homo sapiens proteome-wide analysis: a profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 2010; 4:75-81.